FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1790870835> ?p ?o ?g. }

• W1790870835 endingPage "41" @default.
• W1790870835 startingPage "30" @default.
• W1790870835 abstract "With the technology of reprogramming somatic cells by introducing defined transcription factors that enables the generation of induced pluripotent stem cells (iPSCs) with pluripotency comparable to that of embryonic stem cells (ESCs), it has become possible to use this technology to produce various cells and tissues that have been difficult to obtain from living bodies. This advancement is bringing forth rapid progress in iPSC-based disease modeling, drug screening, and regenerative medicine. More and more studies have demonstrated that phenotypes of adult-onset neurodegenerative disorders could be rather faithfully recapitulated in iPSC-derived neural cell cultures. Moreover, despite the adult-onset nature of the diseases, pathogenic phenotypes and cellular abnormalities often exist in early developmental stages, providing new windows of opportunity for understanding mechanisms underlying neurodegenerative disorders and for discovering new medicines. The cell reprogramming technology enables a reverse engineering approach for modeling the cellular degenerative phenotypes of a wide range of human disorders. An excellent example is the study of the human neurodegenerative disease amyotrophic lateral sclerosis (ALS) using iPSCs. ALS is a progressive neurodegenerative disease characterized by the loss of upper and lower motor neurons (MNs), culminating in muscle wasting and death from respiratory failure. The iPSC approach provides innovative cell culture platforms to serve as ALS patient-derived model systems. Researchers have converted iPSCs derived from ALS patients into MNs and various types of glial cells, all of which are involved in ALS, to study the disease. The iPSC technology could be used to determine the role of specific genetic factors to track down what's wrong in the neurodegenerative disease process in the disease-in-a-dish model. Meanwhile, parallel experiments of targeting the same specific genes in human ESCs could also be performed to control and to complement the iPSC-based approach for ALS disease modeling studies. Much knowledge has been generated from the study of both ALS iPSCs and ESCs. As these methods have advantages and disadvantages that should be balanced on experimental design in order for them to complement one another, combining the diverse methods would help build an expanded knowledge of ALS pathophysiology. The goals are to reverse engineer the human disease using ESCs and iPSCs, generate lineage reporter lines and in vitro disease models, target disease related genes, in order to better understand the molecular and cellular mechanisms of differentiation regulation along neural (neuronal versus glial) lineages, to unravel the pathogenesis of the neurodegenerative disease, and to provide appropriate cell sources for replacement therapy. This article is part of a Special Issue entitled SI: PSC and the brain." @default.
• W1790870835 created "2016-06-24" @default.
• W1790870835 creator A5001959448 @default.
• W1790870835 creator A5060002817 @default.
• W1790870835 date "2016-05-01" @default.
• W1790870835 modified "2023-09-27" @default.
• W1790870835 title "Reverse engineering human neurodegenerative disease using pluripotent stem cell technology" @default.
• W1790870835 cites W1941076503 @default.
• W1790870835 cites W1949129910 @default.
• W1790870835 cites W1967932847 @default.
• W1790870835 cites W1969492143 @default.
• W1790870835 cites W1981394064 @default.
• W1790870835 cites W1982021060 @default.
• W1790870835 cites W1983166842 @default.
• W1790870835 cites W1990078383 @default.
• W1790870835 cites W1992695405 @default.
• W1790870835 cites W1996024251 @default.
• W1790870835 cites W1997804747 @default.
• W1790870835 cites W2001364132 @default.
• W1790870835 cites W2003618511 @default.
• W1790870835 cites W2009108898 @default.
• W1790870835 cites W2010521938 @default.
• W1790870835 cites W2013771570 @default.
• W1790870835 cites W2015735925 @default.
• W1790870835 cites W2018110972 @default.
• W1790870835 cites W2018286352 @default.
• W1790870835 cites W2022367303 @default.
• W1790870835 cites W2026671856 @default.
• W1790870835 cites W2026931179 @default.
• W1790870835 cites W2031964319 @default.
• W1790870835 cites W2033158384 @default.
• W1790870835 cites W2033591223 @default.
• W1790870835 cites W2037074405 @default.
• W1790870835 cites W2039253350 @default.
• W1790870835 cites W2044659434 @default.
• W1790870835 cites W2045435533 @default.
• W1790870835 cites W2053998703 @default.
• W1790870835 cites W2054064334 @default.
• W1790870835 cites W2061727943 @default.
• W1790870835 cites W2063996210 @default.
• W1790870835 cites W2064621113 @default.
• W1790870835 cites W2064815984 @default.
• W1790870835 cites W2065219073 @default.
• W1790870835 cites W2066058435 @default.
• W1790870835 cites W2069244433 @default.
• W1790870835 cites W2073073462 @default.
• W1790870835 cites W2078616043 @default.
• W1790870835 cites W2079870118 @default.
• W1790870835 cites W2080474239 @default.
• W1790870835 cites W2080477348 @default.
• W1790870835 cites W2086689324 @default.
• W1790870835 cites W2088742448 @default.
• W1790870835 cites W2093441343 @default.
• W1790870835 cites W2094979867 @default.
• W1790870835 cites W2099768941 @default.
• W1790870835 cites W2101321540 @default.
• W1790870835 cites W2101687573 @default.
• W1790870835 cites W2107556826 @default.
• W1790870835 cites W2107660300 @default.
• W1790870835 cites W2108038398 @default.
• W1790870835 cites W2108538059 @default.
• W1790870835 cites W2110309782 @default.
• W1790870835 cites W2112538318 @default.
• W1790870835 cites W2113670539 @default.
• W1790870835 cites W2114872355 @default.
• W1790870835 cites W2116314385 @default.
• W1790870835 cites W2118823143 @default.
• W1790870835 cites W2120321527 @default.
• W1790870835 cites W2121396070 @default.
• W1790870835 cites W2123193865 @default.
• W1790870835 cites W2123848058 @default.
• W1790870835 cites W2125741255 @default.
• W1790870835 cites W2125987139 @default.
• W1790870835 cites W2129795133 @default.
• W1790870835 cites W2131321387 @default.
• W1790870835 cites W2135107819 @default.
• W1790870835 cites W2136896331 @default.
• W1790870835 cites W2137007484 @default.
• W1790870835 cites W2138977668 @default.
• W1790870835 cites W2139264742 @default.
• W1790870835 cites W2139747296 @default.
• W1790870835 cites W2140398365 @default.
• W1790870835 cites W2140754284 @default.
• W1790870835 cites W2142046859 @default.
• W1790870835 cites W2144993965 @default.
• W1790870835 cites W2146546145 @default.
• W1790870835 cites W2146729586 @default.
• W1790870835 cites W2147802916 @default.
• W1790870835 cites W2149142681 @default.
• W1790870835 cites W2150523249 @default.
• W1790870835 cites W2154945114 @default.
• W1790870835 cites W2156969855 @default.
• W1790870835 cites W2163304964 @default.
• W1790870835 cites W2167912995 @default.
• W1790870835 cites W2172009886 @default.
• W1790870835 cites W2315191128 @default.
• W1790870835 cites W2407296251 @default.
• W1790870835 cites W26478509 @default.

• next